Elevance Health, Inc. (NYSE:ELV – Get Rating)’s share price hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $438.72 and last traded at $439.50, with a volume of 463130 shares. The stock had previously closed at $445.89. Analyst Ratings Changes A number of brokerages recently issued reports […]
BI Asset Management Fondsmaeglerselskab A S acquired a new position in Elevance Health, Inc. (NYSE:ELV – Get Rating) in the 4th quarter, Holdings Channel.com reports. The firm acquired 81,970 shares of the company’s stock, valued at approximately $42,048,000. Elevance Health comprises approximately 1.1% of BI Asset Management Fondsmaeglerselskab A S’s portfolio, making the stock its […]
DB Wealth Management Group LLC purchased a new stake in shares of Elevance Health, Inc. (NYSE:ELV – Get Rating) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 327 shares of the company’s stock, valued at approximately $168,000. Several other hedge funds also recently modified […]
Carmignac Gestion bought a new stake in shares of Elevance Health, Inc. (NYSE:ELV – Get Rating) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 449,539 shares of the company’s stock, valued at approximately $230,600,000. Elevance Health makes up 4.2% of Carmignac Gestion’s portfolio, […]
PGGM Investments bought a new stake in shares of Elevance Health, Inc. (NYSE:ELV – Get Rating) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 26,273 shares of the company’s stock, valued at approximately $13,477,000. Several other hedge […]